Vitamin E TPGS-derived Nanoformulation to Eradicate Exemestane Biopharmaceutical Hindrances: A Novel Targeted Nanomedicine

References

1. MathurP. SathishkumarK. ChaturvediM. Cancer statistics, 2020: Report from national cancer registry programme, India.JCO Glob. Oncol.2020661063107510.1200/GO.20.0012232673076
   [Google Scholar]
2. LloydM.R. WanderS.A. HamiltonE. RazaviP. BardiaA. Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: Current and emerging role.Ther. Adv. Med. Oncol.20221410.1177/1758835922111369435923930
   [Google Scholar]
3. SinghA. NeupaneY.R. ShafiS. ManglaB. KohliK. PEGylated liposomes as an emerging therapeutic platform for oral nanomedicine in cancer therapy: In vitro and in vivo assessment.J. Mol. Liq.202030311264910.1016/j.molliq.2020.112649
   [Google Scholar]
4. ElzoghbyA.O. El-LakanyS.A. HelmyM.W. Abu-SerieM.M. ElgindyN.A. Shell-crosslinked zein nanocapsules for oral codelivery of exemestane and resveratrol in breast cancer therapy.Nanomedicine201712242785280510.2217/nnm‑2017‑024729094642
   [Google Scholar]
5. MengJ. GuoF. XuH. LiangW. WangC. YangX.D. Combination therapy using co-encapsulated resveratrol and paclitaxel in liposomes for drug resistance reversal in breast cancer cells in vivo.Sci. Rep.2016612239010.1038/srep2239026947928
   [Google Scholar]
6. SinghA. ThakurS. SinghH. Novel Vitamin E TPGS based docetaxel nanovesicle formulation for its safe and effective parenteral delivery: Toxicological, pharmacokinetic and pharmacodynamic evaluation.J. Liposome Res.202131436538010.1080/08982104.2020.183595533050745
   [Google Scholar]
7. LiN. MaiY. LiuQ. GouG. YangJ. Docetaxel-loaded D-α-tocopheryl polyethylene glycol-1000 succinate liposomes improve lung cancer chemotherapy and reverse multidrug resistance.Drug Deliv. Transl. Res.202111113114110.1007/s13346‑020‑00720‑932052357
   [Google Scholar]
8. RajuA. MuthuM.S. FengS.S. Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel.Expert Opin. Drug Deliv.201310674776010.1517/17425247.2013.77742523458409
   [Google Scholar]
9. LiN. FuT. FeiW. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells.J. Pharm. Pharmacol.20197181243125410.1111/jphp.1312631215039
   [Google Scholar]
10. LiuY. SunC. LiW. Preparation and characterization of Syringic acid–loaded TPGS liposome with enhanced oral bioavailability and in vivo antioxidant efficiency.AAPS PharmSciTech20192039810.1208/s12249‑019‑1290‑630719694
    [Google Scholar]
11. HanS.M. BaekJ.S. KimM.S. HwangS.J. ChoC.W. Surface modification of paclitaxel-loaded liposomes using d-α-tocopheryl polyethylene glycol 1000 succinate: Enhanced cellular uptake and cytotoxicity in multidrug resistant breast cancer cells.Chem. Phys. Lipids2018213394710.1016/j.chemphyslip.2018.03.00529550143
    [Google Scholar]
12. RizwanullahM. PerwezA. MirS.R. Alam RizviM.M. AminS. Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: Optimization, in vitro characterization and cell culture studies.Nanotechnology2021324141510110.1088/1361‑6528/ac109834198267
    [Google Scholar]
13. ChaturvediS. GargA. Development and optimization of nanoemulsion containing exemestane using box-behnken design.J. Drug Deliv. Sci. Technol.20238010415110.1016/j.jddst.2023.104151
    [Google Scholar]